skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 565  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial
Material Type:
Article
Add to My Research

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial

The American journal of gastroenterology, 2020-07, Vol.115 (7), p.1055 [Peer Reviewed Journal]

EISSN: 1572-0241 ;DOI: 10.14309/ajg.0000000000000661 ;PMID: 32618656

Full text available

2
Advancing the global public health agenda for NAFLD: a consensus statement
Material Type:
Article
Add to My Research

Advancing the global public health agenda for NAFLD: a consensus statement

Nature reviews. Gastroenterology & hepatology, 2022-01, Vol.19 (1), p.60-78 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;COPYRIGHT 2022 Nature Publishing Group ;Springer Nature Limited 2021. corrected publication 2021. ;ISSN: 1759-5045 ;ISSN: 1759-5053 ;EISSN: 1759-5053 ;DOI: 10.1038/s41575-021-00523-4 ;PMID: 34707258

Full text available

3
Triggering and resolution of inflammation in NASH
Material Type:
Article
Add to My Research

Triggering and resolution of inflammation in NASH

Nature reviews. Gastroenterology & hepatology, 2018-06, Vol.15 (6), p.349-364 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2018 ;ISSN: 1759-5045 ;EISSN: 1759-5053 ;DOI: 10.1038/s41575-018-0009-6 ;PMID: 29740166

Full text available

4
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
Material Type:
Article
Add to My Research

NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

Gut, 2020-09, Vol.69 (9), p.1691-1705 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2020-320622 ;PMID: 32321858

Full text available

5
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement
Material Type:
Article
Add to My Research

Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement

Hepatology (Baltimore, Md.), 2021-07, Vol.74 (1), p.474 [Peer Reviewed Journal]

ISSN: 1527-3350 ;EISSN: 1527-3350 ;DOI: 10.1002/hep.31726

Digital Resources/Online E-Resources

6
NAFLD and diabetes mellitus
Material Type:
Article
Add to My Research

NAFLD and diabetes mellitus

Nature reviews. Gastroenterology & hepatology, 2017-01, Vol.14 (1), p.32-42 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jan 2017 ;ISSN: 1759-5045 ;EISSN: 1759-5053 ;DOI: 10.1038/nrgastro.2016.147 ;PMID: 27729660

Full text available

7
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Material Type:
Article
Add to My Research

PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD

Nature reviews. Endocrinology, 2017-01, Vol.13 (1), p.36-49 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2017 ;ISSN: 1759-5029 ;EISSN: 1759-5037 ;DOI: 10.1038/nrendo.2016.135 ;PMID: 27636730

Full text available

8
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Material Type:
Article
Add to My Research

Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus

Nature reviews. Endocrinology, 2021-08, Vol.17 (8), p.484-495 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;ISSN: 1759-5029 ;EISSN: 1759-5037 ;DOI: 10.1038/s41574-021-00507-z ;PMID: 34131333

Full text available

9
Non-alcoholic fatty liver disease
Material Type:
Article
Add to My Research

Non-alcoholic fatty liver disease

BMC medicine, 2017-02, Vol.15 (1), p.45-45, Article 45 [Peer Reviewed Journal]

Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-017-0806-8 ;PMID: 28241825

Full text available

10
NAFLD - sounding the alarm on a silent epidemic
Material Type:
Article
Add to My Research

NAFLD - sounding the alarm on a silent epidemic

Nature reviews. Gastroenterology & hepatology, 2020-07, Vol.17 (7), p.377-379 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-5045 ;EISSN: 1759-5053 ;DOI: 10.1038/s41575-020-0315-7 ;PMID: 32514153

Full text available

11
Current treatment paradigms and emerging therapies for NAFLD/NASH
Material Type:
Article
Add to My Research

Current treatment paradigms and emerging therapies for NAFLD/NASH

Frontiers in bioscience (Landmark. Print), 2021-01, Vol.26 (2), p.206-237 [Peer Reviewed Journal]

ISSN: 2768-6701 ;EISSN: 2768-6698 ;DOI: 10.2741/4892 ;PMID: 33049668

Full text available

12
Lipid droplets and liver disease: from basic biology to clinical implications
Material Type:
Article
Add to My Research

Lipid droplets and liver disease: from basic biology to clinical implications

Nature reviews. Gastroenterology & hepatology, 2017-06, Vol.14 (6), p.343-355 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2017 ;ISSN: 1759-5045 ;EISSN: 1759-5053 ;DOI: 10.1038/nrgastro.2017.32 ;PMID: 28428634

Full text available

13
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis

The lancet oncology, 2022-04, Vol.23 (4), p.521-530 [Peer Reviewed Journal]

2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(22)00078-X ;PMID: 35255263

Full text available

14
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss
Material Type:
Article
Add to My Research

Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss

BMC endocrine disorders, 2022-03, Vol.22 (1), p.63-63, Article 63 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1472-6823 ;EISSN: 1472-6823 ;DOI: 10.1186/s12902-022-00980-1 ;PMID: 35287643

Full text available

15
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Material Type:
Article
Add to My Research

Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action

Diabetes care, 2017-03, Vol.40 (3), p.419-430 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association Mar 1, 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-1787 ;PMID: 28223446 ;CODEN: DICAD2

Full text available

16
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)
Material Type:
Article
Add to My Research

The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)

Cellular and molecular life sciences : CMLS, 2019-04, Vol.76 (8), p.1541-1558 [Peer Reviewed Journal]

Springer Nature Switzerland AG 2019 ;Cellular and Molecular Life Sciences is a copyright of Springer, (2019). All Rights Reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1420-682X ;EISSN: 1420-9071 ;DOI: 10.1007/s00018-019-03011-w ;PMID: 30683985

Full text available

17
Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
Material Type:
Article
Add to My Research

Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses

Human gene therapy, 2015-07, Vol.26 (7), p.432-442 [Peer Reviewed Journal]

Copyright 2015, Mary Ann Liebert, Inc. 2015 ;ISSN: 1043-0342 ;EISSN: 1557-7422 ;DOI: 10.1089/hum.2015.087 ;PMID: 26086867

Full text available

18
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis
Material Type:
Article
Add to My Research

Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis

Medicine (Baltimore), 2017-09, Vol.96 (39), p.e8179-e8179 [Peer Reviewed Journal]

Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000008179 ;PMID: 28953675

Full text available

19
Management of NAFLD: a stage-based approach
Material Type:
Article
Add to My Research

Management of NAFLD: a stage-based approach

Nature reviews. Gastroenterology & hepatology, 2016-04, Vol.13 (4), p.196-205 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2016 ;ISSN: 1759-5045 ;EISSN: 1759-5053 ;DOI: 10.1038/nrgastro.2016.3 ;PMID: 26907882

Full text available

20
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Material Type:
Article
Add to My Research

Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?

Gastroenterology (New York, N.Y. 1943), 2020-05 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0016-5085 ;EISSN: 1528-0012 ;DOI: 10.1053/j.gastro.2020.01.049

Digital Resources/Online E-Resources

Results 1 - 20 of 565  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (492)

Refine My Results

New Records 

  1. New From Last Month  (5)
  2. New From Last 3 Month  (16)
  3. More options open sub menu

Resource Type 

  1. Articles  (564)
  2. magazinearticle  (1)
  3. More options open sub menu

Language 

  1. English  (557)
  2. Japanese  (112)
  3. Portuguese  (7)
  4. Spanish  (7)
  5. Russian  (4)
  6. French  (4)
  7. Norwegian  (1)
  8. More options open sub menu

Searching Remote Databases, Please Wait